title: Therapeutic challenges in treating patients with fragile X syndrome and neoplasia.
abstract: The administration of cytotoxic therapy to patients with fragile X syndrome (FXS) presents several unique therapeutic challenges. The existence of fragile sites poses a theoretical risk of tumorigenesis and potentially increased treatment associated toxicity, however, controversy exists. We review the 42 previously reported cases of neoplasia in patients with FXS and report two novel neoplasms in patients treated with radiation therapy or combined chemoradiation. Our experience suggests that radiation therapy can be delivered safely in these patients without an expectation for increased acute/sub-acute normal tissue toxicity; however, treatment requires specialized facilities with the resources to deliver this care safely.
authors.affiliation: Department of Radiation Oncology, Baylor College of Medicine, Houston, Texas.
authors.forename: Andrew
authors.initials: A
authors.lastname: Farach
authors.forename: Laura S
authors.initials: LS
authors.lastname: Farach
authors.forename: Arnold C
authors.initials: AC
authors.lastname: Paulino
mesh_terms: D002648:Child; D005600:Fragile X Syndrome / Q000150:complications*; D006801:Humans; D008297:Male; D009369:Neoplasms / Q000150:complications* / Q000628:therapy*; D055815:Young Adult
keywords: Fragile X Syndrome; cancer; chemotherapy; neoplasia; radiation; toxicity